| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |